Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation

scientific article published on April 2014

Neoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.SEMRADONC.2013.11.002
P698PubMed publication ID24635868

P2093author name stringSarah Hoffe
Ravi Shridhar
Nikhil Rao
P2860cites workPortal vein stenosis after pancreatectomy following neoadjuvant chemoradiation therapy for pancreatic cancerQ36821676
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectadaptive radiation therapyQ180507
pancreatic cancerQ212961
P304page(s)113-125
P577publication date2014-04-01
P1433published inSeminars in Radiation OncologyQ14330413
P1476titleNeoadjuvant vs adjuvant therapy for resectable pancreatic cancer: the evolving role of radiation
P478volume24

Reverse relations

cites work (P2860)
Q50068821Activation of PPARα by clofibrate sensitizes pancreatic cancer cells to radiation through the Wnt/β-catenin pathway
Q37032026Comparative long-term outcomes of upfront resected pancreatic cancer after preoperative biliary drainage
Q61811947Comparison of neoadjuvant therapy and upfront surgery in resectable pancreatic cancer: a meta-analysis and systematic review
Q26749037Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy
Q64264140Mutant Gene Found in Pancreatic Juice Activated Chromatin From Peri-ampullary Adenocarcinomas
Q26766686Neoadjuvant radiotherapeutic strategies in pancreatic cancer
Q36062611Outcomes of resected pancreatic cancer in patients age ≥70.
Q64950912The Management of Older Adults with Pancreatic Adenocarcinoma.

Search more.